Medtronic Plc, headquartered in Dublin, develops and sells medical therapies and services, employing 95,000 staff. Its diverse product categories include cardiac, surgical, and respiratory technologies, along with various support services.
MDT has been in the news recently: MEDTRONIC PLC is positioned in the rapidly growing Smart Insulin Pens and Pumps market, which is projected to increase from $5.2 billion in 2023 to $9.2 billion by 2030. Additionally, the company has seen significant growth in 2024, expanding its partnerships and fintech integrations while also benefiting from trends in the Respiratory Care Devices Market, expected to rise from $24.17 billion in 2024 to $49.19 billion by 2033.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!